Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy

被引:210
|
作者
Bouchard, C
Lacroix, C
Planté, V
Adams, D
Chedru, F
Guglielmi, JM
Said, G
机构
[1] Univ Paris 11, Hop Bicetre, Serv Neurol, Orsay, France
[2] Univ Paris 11, Hop Bicetre, Lab Louis Ranvier, Orsay, France
[3] Univ Paris 11, Hop Bicetre, Neuropathol Lab, Orsay, France
[4] Hop Meaux, Serv Neurol, Meaux, France
关键词
D O I
10.1212/WNL.52.3.498
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To evaluate the clinicopathologic features and prognostic factors of 100 patients with chronic inflammatory demyelinating polyneuropathy (CIDP). Methods: Comparison of clinical and biopsy findings with functional score evaluated an average of 6 years after referral. Results: CIDP followed a relapsing course in 14% of the patients and a progressive course in 45%. After progressive onset, little change was noted during follow-up in the others. Five patients had symptomatic involvement of the CNS. Teased fiber preparations of nerve biopsy specimens showed that 68 patients had purely demyelinative lesions, 20 had mixed axonal and demyelinative lesions, and 5 had predominantly axonal lesions. Axonal loss was a common finding, with 47% of the patients retaining less than half of the normal density of fibers. Inflammatory infiltrates, found in 18 samples, were prominent only in 4. Of the 83 patients evaluated an average of 6 years after onset, 56 were in good condition; 24 had deteriorated and failed to respond to treatment, including 9 patients who died as a consequence of their neurologic deficit. Progressive course, CNS involvement, high proportion of fibers showing active demyelination on nerve biopsy, and axonal loss overall correlated with higher disability. Conclusion: Axonal loss is the major long-term pejorative prognostic factor in CIDP.
引用
收藏
页码:498 / 503
页数:6
相关论文
共 50 条
  • [41] Chronic inflammatory demyelinating polyneuropathy (CIDP)
    Van der Meché, FGA
    Van Doorn, PA
    CLINICAL NEUROPHYSIOLOGY: FROM RECEPTORS TO PERCEPTION, 1999, 50 : 493 - 498
  • [42] Immunoglobulins in chronic inflammatory demyelinating polyneuropathy
    G. Comi
    A. Quattrini
    R. Fazio
    L. Roveri
    Neurological Sciences, 2003, 24 : s246 - s250
  • [43] Diagnosis of chronic inflammatory demyelinating polyneuropathy
    Allen, Jeffrey A.
    Lewis, Richard A.
    MUSCLE & NERVE, 2022, 66 (05) : 545 - 551
  • [44] Treatment of chronic inflammatory demyelinating polyneuropathy
    Comi, G
    Roveri, L
    ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1998, 19 (05): : 261 - 269
  • [45] Fatigue in chronic inflammatory demyelinating polyneuropathy
    Lawley, Andrew
    Seri, Stefano
    Rajabally, Yusuf
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 336 - 336
  • [46] Chronic inflammatory demyelinating polyneuropathy in childhood
    Karasoy, H
    Yuceyar, N
    Gokcay, A
    Ekmekci, O
    Ulku, A
    NEUROMUSCULAR DISORDERS, 2001, 11 (6-7) : 659 - 659
  • [47] Chronic inflammatory demyelinating polyneuropathy in children
    Takagi, A.
    Fujii, K.
    Uchikawa, H.
    Misawa, S.
    Kohno, Y.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 205 - 205
  • [48] Treatment of chronic inflammatory demyelinating polyneuropathy
    van Doorn, PA
    Ruts, L
    CURRENT OPINION IN NEUROLOGY, 2004, 17 (05) : 607 - 613
  • [49] Treatment of Chronic Inflammatory Demyelinating Polyneuropathy
    Robertson, Eliza E.
    Donofrio, Peter D.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2010, 12 (02) : 84 - 94
  • [50] Lmmunoglobulins in chronic inflammatory demyelinating polyneuropathy
    Comi, G
    Quattrini, A
    Fazio, R
    Roveri, L
    NEUROLOGICAL SCIENCES, 2003, 24 (Suppl 4) : S246 - S250